Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Approvals Action
One prescription drug added

Posted 22 December 2020 

Seqirus was the sole sponsor to register a prescription drug on the ARTG over the last week with the TGA ticking its eye drop treatment for patients with dry eyes.

The registration of Ikervis makes Seqirus the second company to register active ingredient ciclosporin for the indication following Sun Pharma's entry of Cequa earlier this year.

Novartis also has products containing ciclosporin that are used as an immunosuppressive agent following transplantation and inflammatory diseases. Neoral and Sandimmun are PBS listed.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
PBAC March agenda
Every major and minor sub sorted by indication
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas
Special Report
November 2020 PBAC outcomes
Just over half of submissions recommended